Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
Rik RozemeijerMèra SteinPeter FrambachMichiel VoskuilAdriaan O KraaijeveldRamón Rodríguez-OlivaresLeo TimmersBruno PereiraSaskia Z RittersmaPierfrancesco AgostoniPieter A DoevendansPieter R StellaPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
ReCre8 (NCT02328898) is the first randomized multicenter trial with a head-to-head comparison of A-SES as compared with ZES to investigate the clinical safety and efficacy of these new-generation DES in a real-world, all-comers population.
Keyphrases
- double blind
- phase iii
- placebo controlled
- clinical trial
- percutaneous coronary intervention
- phase ii
- study protocol
- optic nerve
- open label
- acute coronary syndrome
- acute myocardial infarction
- cross sectional
- st elevation myocardial infarction
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- randomized controlled trial
- heart failure
- coronary artery bypass